- Denmark
- /
- Medical Equipment
- /
- CPSE:DEMANT
Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price
Key Insights
- Demant's estimated fair value is kr.392 based on 2 Stage Free Cash Flow to Equity
- Current share price of kr.293 suggests Demant is potentially 25% undervalued
- The kr.286 analyst price target for DEMANT is 27% less than our estimate of fair value
In this article we are going to estimate the intrinsic value of Demant A/S (CPH:DEMANT) by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Don't get put off by the jargon, the math behind it is actually quite straightforward.
We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.
View our latest analysis for Demant
Crunching The Numbers
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
10-year free cash flow (FCF) forecast
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (DKK, Millions) | kr.2.71b | kr.3.10b | kr.3.12b | kr.3.75b | kr.4.02b | kr.4.23b | kr.4.39b | kr.4.51b | kr.4.61b | kr.4.68b |
Growth Rate Estimate Source | Analyst x7 | Analyst x7 | Analyst x3 | Analyst x2 | Est @ 7.15% | Est @ 5.17% | Est @ 3.78% | Est @ 2.81% | Est @ 2.13% | Est @ 1.65% |
Present Value (DKK, Millions) Discounted @ 5.5% | kr.2.6k | kr.2.8k | kr.2.7k | kr.3.0k | kr.3.1k | kr.3.1k | kr.3.0k | kr.2.9k | kr.2.9k | kr.2.8k |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = kr.29b
The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.5%. We discount the terminal cash flows to today's value at a cost of equity of 5.5%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = kr.4.7b× (1 + 0.5%) ÷ (5.5%– 0.5%) = kr.96b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= kr.96b÷ ( 1 + 5.5%)10= kr.56b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is kr.85b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of kr.293, the company appears a touch undervalued at a 25% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
Important Assumptions
We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Demant as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.5%, which is based on a levered beta of 0.984. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Demant
- Debt is well covered by earnings and cashflows.
- Earnings declined over the past year.
- Annual earnings are forecast to grow faster than the Danish market.
- Good value based on P/E ratio and estimated fair value.
- Annual revenue is forecast to grow slower than the Danish market.
Moving On:
Whilst important, the DCF calculation ideally won't be the sole piece of analysis you scrutinize for a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. Why is the intrinsic value higher than the current share price? For Demant, we've put together three further elements you should explore:
- Risks: You should be aware of the 1 warning sign for Demant we've uncovered before considering an investment in the company.
- Future Earnings: How does DEMANT's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the CPSE every day. If you want to find the calculation for other stocks just search here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About CPSE:DEMANT
Demant
Operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally.
Undervalued with moderate growth potential.